Marco Taglietti, M.D., is the Chief Executive Officer of SCYNEXIS, a pharmaceutical company focused on the discovery, development.
Marco Taglietti, M.D., is the Chief Executive Officer of SCYNEXIS, a pharmaceutical company focused on the discovery, development, and commercialization of novel anti-infectives. He assumed the CEO role on April 1, 2015, after joining the company's Board of Directors in December 2014. Prior to SCYNEXIS, Dr. Taglietti held executive positions at Forest Laboratories, Inc. and Stiefel Laboratories, Inc., and served at Schering-Plough Corporation, with extensive experience in drug development across various therapeutic areas.
Full founder directory · Investor directory · Company funding database · Fundraising library